This work is licensed under the Creative Commons Attribution 4.0 International License.
Baden LR, Rubin EJ. Covid-19 - The search for effective therapy. N Engl J Med. 2020;382:1851-2.BadenLRRubinEJCovid-19 - The search for effective therapy20203821851210.1056/NEJMe2005477712144632187463Search in Google Scholar
Berlin DA, Gulick RM, Martinez FJ. Severe Covid-19. N Engl J Med. 2020;383:2451-60.BerlinDAGulickRMMartinezFJSevere Covid-19202038324516010.1056/NEJMcp200957532412710Search in Google Scholar
Karakuzu Z, Iscimen R, Akalin H, Kelebek Girgin N, Kahveci F, Sinirtas M. Prognostic risk factors in ventilator-associated pneumonia. Med Sci Monit. 2018;24:1321-8.KarakuzuZIscimenRAkalinHKelebekGirgin NKahveciFSinirtasMPrognostic risk factors in ventilator-associated pneumonia2018241321810.12659/MSM.905919584871529503436Search in Google Scholar
Grasselli G, Scaravilli V, Mangioni D, Scudeller L, Alagna L, Bartoletti M, et al. Hospital-Acquired Infections in Critically Ill Patients With COVID-19. Chest. 2021;160:454–65.GrasselliGScaravilliVMangioniDScudellerLAlagnaLBartolettiMet alHospital-Acquired Infections in Critically Ill Patients With COVID-1920211604546510.1016/j.chest.2021.04.002805684433857475Search in Google Scholar
Sharifipour E, Shams S, Esmkhani M, Khodadadi J, Fotouhi-Ardakani R, Koohpaei A, et al. Evaluation of bacterial co-infections of the respiratory tract in COVID-19 patients admitted to ICU. Bmc Infect Dis. 2020;20:646.SharifipourEShamsSEsmkhaniMKhodadadiJFotouhi-ArdakaniRKoohpaeiAet alEvaluation of bacterial co-infections of the respiratory tract in COVID-19 patients admitted to ICU20202064610.1186/s12879-020-05374-z746175332873235Search in Google Scholar
Shekar K, Fraser JF, Smith MT, Roberts JA. Pharmacokinetic changes in patients receiving extracorporeal membrane oxygenation. J Crit Care. 2012;27:741.e9-18.ShekarKFraserJFSmithMTRobertsJAPharmacokinetic changes in patients receiving extracorporeal membrane oxygenation201227741e9-1810.1016/j.jcrc.2012.02.01322520488Search in Google Scholar
Chen GJ, Lin SW, Tsai IL, Kuo CH, Wang JT, Hsieh SM. Therapeutic drug monitoring of the teicoplanin trough level after the loading doses in patients receiving venoarterial extracorporeal membrane oxygenation. J Formos Med Assoc. 2020;119:1086-92.ChenGJLinSWTsaiILKuoCHWangJTHsiehSMTherapeutic drug monitoring of the teicoplanin trough level after the loading doses in patients receiving venoarterial extracorporeal membrane oxygenation202011910869210.1016/j.jfma.2019.10.00531672434Search in Google Scholar
Wi J, Noh H, Min KL, et al. Population pharmacokinetics and dose optimization of teicoplanin during venoarterial extracorporeal membrane oxygenation. Antimicrob Agents Chemother. 2017;61:e01015-17.WiJNohHMinKLet alPopulation pharmacokinetics and dose optimization of teicoplanin during venoarterial extracorporeal membrane oxygenation201761e010151710.1128/AAC.01015-17557134828674057Search in Google Scholar
Nakamura A, Takasu O, Sakai Y, et al. Development of a teicoplanin loading regimen that rapidly achieves target serum concentrations in critically ill patients with severe infections. J Infect Chemother. 2015;21:449-55.NakamuraATakasuOSakaiYet alDevelopment of a teicoplanin loading regimen that rapidly achieves target serum concentrations in critically ill patients with severe infections2015214495510.1016/j.jiac.2015.02.00225726436Search in Google Scholar
Mimoz O, Rolland D, Adoun M, et al. Steady-state trough serum and epithelial lining fluid concentrations of teicoplanin 12 mg/ kg per day in patients with ventilator-associated pneumonia. Intensive Care Med. 2006;32:775-9.MimozORollandDAdounMet alSteady-state trough serum and epithelial lining fluid concentrations of teicoplanin 12 mg/ kg per day in patients with ventilator-associated pneumonia200632775910.1007/s00134-006-0136-316550370Search in Google Scholar
Ulldemolins M, Roberts JA, Rello J, Paterson DL, Lipman J. The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients. Clin Pharmacokinet. 2011;50:99110.UlldemolinsMRobertsJARelloJPatersonDLLipmanJThe effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients2011509911010.2165/11539220-000000000-0000021142293Search in Google Scholar
Shiraishi Y, Okajima M, Sai Y, Miyamoto K, Inaba H. Elimination of teicoplanin by adsorption to the filter membrane during haemodiafiltration: screening experiments for linezolid, teicoplanin and vancomycin followed by in vitro haemodiafiltration models for teicoplanin. Anaesth Intensive Care. 2012;40:442–9.ShiraishiYOkajimaMSaiYMiyamotoKInabaHElimination of teicoplanin by adsorption to the filter membrane during haemodiafiltration: screening experiments for linezolid, teicoplanin and vancomycin followed by in vitro haemodiafiltration models for teicoplanin201240442910.1177/0310057X120400030922577909Search in Google Scholar
Svetitsky S, Leibovici L, Paul M. Comparative efficacy and safety of vancomycin versus teicoplanin: systematic review and meta-analysis. Antimicrob Agents Chemother. 2009;53:406979.SvetitskySLeiboviciLPaulMComparative efficacy and safety of vancomycin versus teicoplanin: systematic review and meta-analysis20095340697910.1128/AAC.00341-09276416319596875Search in Google Scholar
Zhang J, Ma X, Yu F, et al. Teicoplanin potently blocks the cell entry of 2019-nCoV. Biorxiv. 2020. doi:10.1101/2020.02.05.935387. [Epub ahead of print]ZhangJMaXYuFet alTeicoplanin potently blocks the cell entry of 2019-nCoV202010.1101/2020.02.05.935387.[Epubaheadofprint]Open DOISearch in Google Scholar